Cite
HARVARD Citation
Hoffman, D. et al. (n.d.). PATH-40. TARGETED NEXT GENERATION SEQUENCING (NGS) OF YOUNG ADULTS WITH ISOCITRATE-DEHYDROGENASE WILD-TYPE GLIOBLASTOMA (IDH-WT GBM) REVEALS NEGATIVE PROGNOSTIC IMPACT OF EPIDERMAL GROWTH FACTOR RECEPTOR AMPLIFICATION (EGFRAMP). Neuro-oncology. p. vi167. [Online].